[HTML][HTML] Optimal medical therapy with or without PCI for stable coronary disease

WE Boden, RA O'Rourke, KK Teo… - New England journal …, 2007 - Mass Medical Soc
Background In patients with stable coronary artery disease, it remains unclear whether an
initial management strategy of percutaneous coronary intervention (PCI) with intensive …

[HTML][HTML] Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study

…, A Avezum, GB Oliveira, CS Marcilio, AC Mattos, K Teo… - The Lancet, 2017 - thelancet.com
Background The relationship between macronutrients and cardiovascular disease and
mortality is controversial. Most available data are from European and North American …

Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials

KK Teo, S Yusuf, CD Furberg - Jama, 1993 - jamanetwork.com
Objective. —To investigate the effects of prophylactic therapy with antiarrhythmic agents on
mortality in patients with myocardial infarction. Data Sources and Study Selection. —Data …

Why do patients with atrial fibrillation not receive warfarin?

TJ Bungard, WA Ghali, KK Teo… - Archives of internal …, 2000 - jamanetwork.com
Atrial fibrillation (AF) is a growing public health problem associated with significant morbidity
and mortality. Numerous randomized controlled trials of warfarin have conclusively …

Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries

CK Chow, KK Teo, S Rangarajan, S Islam, R Gupta… - Jama, 2013 - jamanetwork.com
Importance Hypertension is the most important preventable cause of morbidity and mortality
globally, yet there are relatively few data collected using standardized methods. Objective …

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

…, S Chaithiraphan, K Dickstein, M Keltai, K Metsärinne… - The Lancet, 2008 - thelancet.com
Background Angiotensin receptor blockers (ARB) and angiotensin converting enzyme (ACE)
inhibitors are known to reduce proteinuria. Their combination might be more effective than …

Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization …

…, E Veledar, ER Bates, B McCallister, KK Teo… - Circulation, 2008 - Am Heart Assoc
Background— Extent and severity of myocardial ischemia are determinants of risk for patients
with coronary artery disease, and ischemia reduction is an important therapeutic goal. The …

Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study

KK Teo, S Ounpuu, S Hawken, MR Pandey, V Valentin… - The lancet, 2006 - thelancet.com
Background Tobacco use is one of the major avoidable causes of cardiovascular diseases.
We aimed to assess the risks associated with tobacco use (both smoking and non-smoking) …

Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study

…, R Gupta, SA Lear, A Oguz, K Yusoff, K Zatonska… - The lancet, 2015 - thelancet.com
Background Reduced muscular strength, as measured by grip strength, has been associated
with an increased risk of all-cause and cardiovascular mortality. Grip strength is appealing …

Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a …

…, R Diaz, K Yusoff, P Mony, J Chifamba, K Yeates… - The Lancet, 2020 - thelancet.com
Background Global estimates of the effect of common modifiable risk factors on cardiovascular
disease and mortality are largely based on data from separate studies, using different …